A Gain‐of‐Function Variant in Dopamine D2 Receptor and Progressive Chorea and Dystonia Phenotype

We describe a 4‐generation Dutch pedigree with a unique dominantly inherited clinical phenotype of a combined progressive chorea and cervical dystonia carrying a novel heterozygous dopamine D2 receptor (DRD2) variant.

[1]  K. Neve,et al.  Arrestin recruitment to dopamine D2 receptor mediates locomotion but not incentive motivation , 2018, Molecular Psychiatry.

[2]  A. Mishra,et al.  Physiological and Functional Basis of Dopamine Receptors and Their Role in Neurogenesis: Possible Implication for Parkinson’s disease , 2018, Journal of experimental neuroscience.

[3]  I. Pavlova,et al.  Effects of Blockade of D1 and D2 Receptors in the Basolateral Amygdala on the Behavior of Rats with High and Low Levels of Anxiety and Fear , 2016, Neuroscience and Behavioral Physiology.

[4]  V. Gurevich,et al.  G protein-coupled receptor kinases as regulators of dopamine receptor functions. , 2016, Pharmacological research.

[5]  Jung Hoon Shin,et al.  Enhanced GABA Transmission Drives Bradykinesia Following Loss of Dopamine D2 Receptor Signaling , 2016, Neuron.

[6]  Sylvain Houle,et al.  Lack of Age-Dependent Decrease in Dopamine D3 Receptor Availability: A [11C]-(+)-PHNO and [11C]-Raclopride Positron Emission Tomography Study , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[7]  T. Daigle,et al.  Targeting β-arrestin2 in the treatment of l-DOPA–induced dyskinesia in Parkinson’s disease , 2015, Proceedings of the National Academy of Sciences.

[8]  R. Barker,et al.  Movement disorders and psychiatry: Five new things. , 2015, Neurology. Clinical practice.

[9]  A. Schapira,et al.  Pathogenic mechanisms of neurodegeneration in Parkinson disease. , 2015, Neurologic clinics.

[10]  J. Javitch,et al.  Upregulation of Dopamine D2 Receptors in the Nucleus Accumbens Indirect Pathway Increases Locomotion but Does Not Reduce Alcohol Consumption , 2015, Neuropsychopharmacology.

[11]  K. Neve,et al.  Mutation of Three Residues in the Third Intracellular Loop of the Dopamine D2 Receptor Creates an Internalization-defective Receptor* , 2014, The Journal of Biological Chemistry.

[12]  John T. Williams,et al.  Spontaneous Inhibitory Synaptic Currents Mediated by a G Protein-Coupled Receptor , 2013, Neuron.

[13]  T. Sotnikova,et al.  Beyond cAMP: The Regulation of Akt and GSK3 by Dopamine Receptors , 2011, Front. Mol. Neurosci..

[14]  J. Beaulieu,et al.  Role of Beta-Arrestin 2 Downstream of Dopamine Receptors in the Basal Ganglia , 2011, Front. Neuroanat..

[15]  A. Korchounov,et al.  Postsynaptic nigrostriatal dopamine receptors and their role in movement regulation , 2010, Journal of Neural Transmission.

[16]  C. Lüscher,et al.  Emerging roles for G protein-gated inwardly rectifying potassium (GIRK) channels in health and disease , 2010, Nature Reviews Neuroscience.

[17]  K. Neve,et al.  A Dopamine D2 Receptor Mutant Capable of G Protein-Mediated Signaling but Deficient in Arrestin Binding , 2007, Molecular Pharmacology.

[18]  John T. Williams,et al.  Long-Term Depression of a Dopamine IPSC , 2007, The Journal of Neuroscience.

[19]  R. Lefkowitz,et al.  β-Arrestins and Cell Signaling , 2007 .

[20]  C. Pagès,et al.  Unraveling a role for dopamine in Huntington's disease: the dual role of reactive oxygen species and D2 receptor stimulation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[21]  D. Grandy,et al.  Vesicular Dopamine Release Elicits an Inhibitory Postsynaptic Current in Midbrain Dopamine Neurons , 2004, Neuron.

[22]  M. Brin,et al.  Phenotypic features of myoclonus-dystonia in three kindreds , 2002, Neurology.

[23]  Stephen J. Fink,et al.  Evaluation of the role of the D2 dopamine receptor in myoclonus dystonia , 2000, Annals of neurology.

[24]  A. Rossi,et al.  The emergence of social phobia during clozapine treatment and its response to fluoxetine augmentation. , 1999, The Journal of clinical psychiatry.

[25]  S Fahn,et al.  Association of a missense change in the D2 dopamine receptor with myoclonus dystonia. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[26]  M. Low,et al.  Locomotor Activity in D2 Dopamine Receptor-Deficient Mice Is Determined by Gene Dosage, Genetic Background, and Developmental Adaptations , 1998, The Journal of Neuroscience.

[27]  A. Saiardi,et al.  Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors , 1995, Nature.

[28]  R. Rodgers,et al.  Dopamine D1 and D2 receptor ligands modulate the behaviour of mice in the elevated plus-maze , 1994, Pharmacology Biochemistry and Behavior.

[29]  P. Pauwels,et al.  Review: Amino acid domains involved in constitutive activation of G-protein-coupled receptors , 2007, Molecular Neurobiology.

[30]  K. Eidne,et al.  Bioluminescence resonance energy transfer (BRET) for the real-time detection of protein-protein interactions , 2006, Nature Protocols.